Clinical Trial Update: Chronic Hepatitis C Virus Related Thrombocytopenia to Evaluate the Effects of E5501 [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating E5501 for hepatitis C virus–related thrombocytopenia has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C
• Thrombocytopenia

Drugs mentioned

• E5501

Snippet

Sponsor: Eisai Inc. | Conditions: Thrombocytopenia | Phase 2 | Status: COMPLETED | Results posted: 2018-02-22